HEXO (TSE:HEXO) and The Supreme Cannabis (TSE:FIRE) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, profitability, risk, analyst recommendations, valuation, earnings and institutional ownership.
Analyst Ratings
This is a breakdown of current ratings for HEXO and The Supreme Cannabis, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
HEXO | 0 | 2 | 0 | 1 | 2.67 |
The Supreme Cannabis | 0 | 0 | 0 | 0 | N/A |
HEXO currently has a consensus price target of C$1.76, suggesting a potential downside of 76.41%. The Supreme Cannabis has a consensus price target of C$0.35, suggesting a potential downside of 9.09%. Given The Supreme Cannabis' higher probable upside, analysts plainly believe The Supreme Cannabis is more favorable than HEXO.
Profitability
This table compares HEXO and The Supreme Cannabis' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
HEXO | N/A | N/A | N/A |
The Supreme Cannabis | N/A | N/A | N/A |
Valuation and Earnings
This table compares HEXO and The Supreme Cannabis' top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
HEXO | C$111.62 million | 8.18 | C$-247,219,720.00 | C($2.02) | -3.69 |
The Supreme Cannabis | C$49.44 million | 5.72 | C$-153,549,792.00 | C($0.21) | -1.84 |
The Supreme Cannabis has lower revenue, but higher earnings than HEXO. HEXO is trading at a lower price-to-earnings ratio than The Supreme Cannabis, indicating that it is currently the more affordable of the two stocks.
Summary
The Supreme Cannabis beats HEXO on 4 of the 7 factors compared between the two stocks.